Status:
COMPLETED
Effects of Qigong on Type 2 Diabetic Patients
Lead Sponsor:
Bastyr University
Collaborating Sponsors:
Seattle Foundation
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Qigong therapy is a subtle energy-based methodology for preventing and healing diseases that has been practiced with remarkable results in China for about five thousand years. Recently, preliminary st...
Eligibility Criteria
Inclusion
- Diagnosed with type 2 diabetes defined as a glycohemoglobin between 7.5% and 10.5%, and fasting insulin level \<40 (IU/ml).
- Must be controlling their diabetes with diet or may be taking oral medication for at least three months
- Age 18-65
- Ability to physically perform Qigong or low-intensity physical exercise
- Body Mass Index 18-40
- Have current primary care
- Willing to monitor blood glucose at least twice a day
- Willing to maintain a consistent diet during the study, and
- Sign informed consent
Exclusion
- Significant kidney, liver or heart disease
- History of drug or alcohol abuse within the past 2 years
- Current or previous use of insulin
- Use of dietary supplements that affect blood glucose or insulin
- Current practice of Qigong (any style)
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00885846
Start Date
June 1 2007
End Date
May 1 2008
Last Update
November 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bastyr University Research Center
Kenmore, Washington, United States, 98028-4966